Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 6
2004 5
2005 7
2006 7
2007 4
2008 7
2009 9
2010 6
2011 7
2012 8
2013 7
2014 4
2015 13
2016 14
2017 13
2018 25
2019 23
2020 25
2021 31
2022 30
2023 34
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

260 results

Results by year

Filters applied: . Clear all
Page 1
A Piezo1/KLF15/IL-6 axis mediates immobilization-induced muscle atrophy.
Hirata Y, Nomura K, Kato D, Tachibana Y, Niikura T, Uchiyama K, Hosooka T, Fukui T, Oe K, Kuroda R, Hara Y, Adachi T, Shibasaki K, Wake H, Ogawa W. Hirata Y, et al. Among authors: ogawa w. J Clin Invest. 2022 May 16;132(10):1-13. doi: 10.1172/JCI154611. J Clin Invest. 2022. PMID: 35290243 Free PMC article.
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial.
Kadowaki T, Isendahl J, Khalid U, Lee SY, Nishida T, Ogawa W, Tobe K, Yamauchi T, Lim S; STEP 6 investigators. Kadowaki T, et al. Among authors: ogawa w. Lancet Diabetes Endocrinol. 2022 Mar;10(3):193-206. doi: 10.1016/S2213-8587(22)00008-0. Epub 2022 Feb 4. Lancet Diabetes Endocrinol. 2022. PMID: 35131037 Clinical Trial.
Stimulatory effect of imeglimin on incretin secretion.
Yingyue Q, Sugawara K, Takahashi H, Yokoi N, Ohbayashi K, Iwasaki Y, Seino S, Ogawa W. Yingyue Q, et al. Among authors: ogawa w. J Diabetes Investig. 2023 Jun;14(6):746-755. doi: 10.1111/jdi.14001. Epub 2023 Mar 28. J Diabetes Investig. 2023. PMID: 36977210 Free PMC article.
Insulin resistance and adipose tissue.
Ogawa W. Ogawa W. Diabetol Int. 2023 Mar 28;14(2):117-118. doi: 10.1007/s13340-023-00625-1. eCollection 2023 Apr. Diabetol Int. 2023. PMID: 37090126 Free PMC article. Review. No abstract available.
Insulin resistance in adipose tissue and metabolic diseases.
Imi Y, Ogawa W, Hosooka T. Imi Y, et al. Among authors: ogawa w. Diabetol Int. 2022 Dec 22;14(2):119-124. doi: 10.1007/s13340-022-00616-8. eCollection 2023 Apr. Diabetol Int. 2022. PMID: 37090134 Free PMC article. Review.
The PDK1-FoxO1 signaling in adipocytes controls systemic insulin sensitivity through the 5-lipoxygenase-leukotriene B4 axis.
Hosooka T, Hosokawa Y, Matsugi K, Shinohara M, Senga Y, Tamori Y, Aoki C, Matsui S, Sasaki T, Kitamura T, Kuroda M, Sakaue H, Nomura K, Yoshino K, Nabatame Y, Itoh Y, Yamaguchi K, Hayashi Y, Nakae J, Accili D, Yokomizo T, Seino S, Kasuga M, Ogawa W. Hosooka T, et al. Among authors: ogawa w. Proc Natl Acad Sci U S A. 2020 May 26;117(21):11674-11684. doi: 10.1073/pnas.1921015117. Epub 2020 May 11. Proc Natl Acad Sci U S A. 2020. PMID: 32393635 Free PMC article.
260 results